{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:29:32Z","timestamp":1792718972276,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204125"],"award-info":[{"award-number":["82204125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["24QA2701000"],"award-info":[{"award-number":["24QA2701000"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aohep.2025.102139","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:56:31Z","timestamp":1760223391000},"page":"102139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparisons of global incidence and risk factor profiles of hepatocellular carcinoma and intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Tianhao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2025.102139_bib0001","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.aohep.2025.102139_bib0002","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.aohep.2025.102139_bib0003","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/hep.32007","article-title":"Comparison of clinical features and outcomes between intrahepatic cholangiocarcinoma and hepatocellular carcinoma in the United States","volume":"74","author":"Lee","year":"2021","journal-title":"Hepatol (Baltim Md)"},{"issue":"4","key":"10.1016\/j.aohep.2025.102139_bib0004","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on patient prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.aohep.2025.102139_bib0005","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Management of hepatocellular carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.aohep.2025.102139_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113182","article-title":"Non-alcoholic steatohepatitis as a risk factor for intrahepatic cholangiocarcinoma and its prognostic role","volume":"12","author":"De Lorenzo","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.aohep.2025.102139_bib0007","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","article-title":"Clinical practice guidelines on the management of intrahepatic cholangiocarcinoma","volume":"79","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2025.102139_bib0008","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ijc.32723","article-title":"International trends in hepatocellular carcinoma incidence, 1978-2012","volume":"147","author":"Petrick","year":"2020","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.aohep.2025.102139_bib0009","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/cncr.32803","article-title":"Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012","volume":"126","author":"Florio","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.aohep.2025.102139_bib0010","article-title":"25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis","volume":"384","author":"Shelton","year":"2024","journal-title":"BMJ (Clin Res Ed)"},{"issue":"4","key":"10.1016\/j.aohep.2025.102139_bib0011","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41416-022-02053-5","article-title":"UK Biobank: a globally important resource for cancer research","volume":"128","author":"Conroy","year":"2023","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.aohep.2025.102139_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0002887","article-title":"Risk factors for ill health: how do we specify what is 'modifiable'?","volume":"4","author":"Alwan","year":"2024","journal-title":"PLOS Glob Public Health"},{"issue":"6","key":"10.1016\/j.aohep.2025.102139_bib0013","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: from new variants to the clinic","volume":"72","author":"Tr\u00e9po","year":"2020","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2025.102139_bib0014","article-title":"Mendelian randomization","volume":"12","author":"Birney","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7944","key":"10.1016\/j.aohep.2025.102139_bib0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.aohep.2025.102139_bib0016","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102139_bib0017","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1177\/0962280219848471","article-title":"Attributable fraction for multiple risk factors: methods, interpretations, and examples","volume":"29","author":"Di Maso","year":"2020","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"10.1016\/j.aohep.2025.102139_bib0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.aohep.2025.102139_bib0019","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1136\/gutjnl-2023-330691","article-title":"Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people","volume":"72","author":"Liu","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.aohep.2025.102139_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.21037\/hbsn-21-75","article-title":"Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries","volume":"12","author":"An","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"5","key":"10.1016\/j.aohep.2025.102139_bib0021","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1148\/rg.210206","article-title":"Morphomolecular classification update on hepatocellular adenoma, hepatocellular carcinoma, and intrahepatic cholangiocarcinoma","volume":"42","author":"Katabathina","year":"2022","journal-title":"Radiographics"},{"issue":"8","key":"10.1016\/j.aohep.2025.102139_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100604","article-title":"Proteome landscapes of human hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"22","author":"Yi","year":"2023","journal-title":"Mol Cell Proteom"},{"issue":"10","key":"10.1016\/j.aohep.2025.102139_bib0023","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.aohep.2025.102139_bib0024","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/ijc.35244","article-title":"Total testosterone, sex hormone-binding globulin, and free testosterone concentrations and risk of primary liver cancer: a prospective analysis of 200,000 men and 180,000 postmenopausal women","volume":"156","author":"Watling","year":"2025","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.aohep.2025.102139_bib0025","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10620-020-06498-7","article-title":"Incidence of hepatocellular carcinoma in primary biliary cholangitis: a systematic review and meta-analysis","volume":"66","author":"Natarajan","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.aohep.2025.102139_bib0026","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1158\/1055-9965.EPI-20-1241","article-title":"Hepatobiliary cancer risk in patients with inflammatory bowel disease: a Scandinavian population-based cohort study","volume":"30","author":"Erichsen","year":"2021","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"10.1016\/j.aohep.2025.102139_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90175-w","article-title":"Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies","volume":"11","author":"Aune","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.aohep.2025.102139_bib0028","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/gast.2002.36021","article-title":"p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma","volume":"123","author":"Taniai","year":"2002","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.aohep.2025.102139_bib0029","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00018-017-2472-6","article-title":"ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population","volume":"74","author":"Andress","year":"2017","journal-title":"Cell Mol Life Sci"},{"issue":"4 Pt B","key":"10.1016\/j.aohep.2025.102139_bib0030","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.bbadis.2017.08.020","article-title":"Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma","volume":"1864","author":"Chung","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"10.1016\/j.aohep.2025.102139_bib0031","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0168-8278(97)80356-X","article-title":"Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?","volume":"27","author":"Harnois","year":"1997","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2025.102139_bib0032","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4254\/wjh.v14.i2.319","article-title":"Hepatobiliary manifestations in inflammatory bowel disease: a practical approach","volume":"14","author":"N\u00fa\u00f1ez","year":"2022","journal-title":"World J Hepatol"},{"issue":"12","key":"10.1016\/j.aohep.2025.102139_bib0033","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4254\/wjh.v13.i12.1956","article-title":"Liver manifestations and complications in inflammatory bowel disease: a review","volume":"13","author":"Gaspar","year":"2021","journal-title":"World J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2025.102139_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2022.01.039","article-title":"Increased risk of MAFLD and liver fibrosis in inflammatory bowel disease independent of classic metabolic risk factors","volume":"21","author":"Rodriguez-Duque","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2025.102139_bib0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.trecan.2022.01.013","article-title":"The spectrum of sex differences in cancer","volume":"8","author":"Rubin","year":"2022","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.aohep.2025.102139_bib0036","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2015.09.008","article-title":"Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management","volume":"379","author":"Zhang","year":"2016","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.aohep.2025.102139_bib0037","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.32779","article-title":"Risk stratification and early detection biomarkers for precision HCC screening","volume":"78","author":"Lee","year":"2023","journal-title":"Hepatol (Baltim Md)"},{"issue":"4","key":"10.1016\/j.aohep.2025.102139_bib0038","doi-asserted-by":"crossref","DOI":"10.70322\/fibrosis.2024.10006","article-title":"Sex and gender differences in liver fibrosis: pathomechanisms and clinical outcomes","volume":"2","author":"Jamalinia","year":"2024","journal-title":"Fibrosis"},{"issue":"8010","key":"10.1016\/j.aohep.2025.102139_bib0039","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/d41586-024-01205-2","article-title":"Male-female comparisons are powerful in biomedical research - don't abandon them","volume":"629","author":"Arnold","year":"2024","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.aohep.2025.102139_bib0040","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/HEP.0000000000000277","article-title":"Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review","volume":"79","author":"Toniutto","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2025.102139_bib0041","first-page":"83","article-title":"Sex disparity in hepatocellular carcinoma owing to NAFLD and non-NAFLD etiology: epidemiological findings and pathobiological mechanisms","volume":"6","author":"Amedeo","year":"2020","journal-title":"Hepatoma Res"},{"issue":"7","key":"10.1016\/j.aohep.2025.102139_bib0042","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1097\/MCG.0000000000001693","article-title":"Aspirin use and the risk of hepatocellular carcinoma: a meta-analysis","volume":"56","author":"Wang","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.aohep.2025.102139_bib0043","article-title":"Systematic review with network meta-analysis: antidiabetic medication and risk of hepatocellular carcinoma","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.aohep.2025.102139_bib0044","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.tem.2024.12.009","article-title":"Widening research horizons on metabolic dysfunction-associated steatotic liver disease and cancer","volume":"36","author":"Lonardo","year":"2025","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.aohep.2025.102139_bib0045","article-title":"Global, regional, and national burden of primary liver cancer attributable to metabolic risks: an analysis of the global burden of disease study 1990-2021","author":"Wu","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.aohep.2025.102139_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14060305","article-title":"Prognostic impact of metabolic syndrome and steatotic liver disease in hepatocellular carcinoma using machine learning techniques","volume":"14","author":"Gil-Rojas","year":"2024","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.aohep.2025.102139_bib0047","doi-asserted-by":"crossref","first-page":"20","DOI":"10.20517\/mtod.2022.28","article-title":"Cancer in individuals with obesity and metabolic disorders. A preventable epidemic?","volume":"2","author":"Fulvio","year":"2022","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.aohep.2025.102139_bib0048","doi-asserted-by":"crossref","DOI":"10.37349\/emed.2025.1001334","article-title":"Liver and obesity: a narrative review","volume":"6","author":"Lonardo","year":"2025","journal-title":"Explor Med"},{"issue":"1","key":"10.1016\/j.aohep.2025.102139_bib0049","doi-asserted-by":"crossref","first-page":"5","DOI":"10.20517\/mtod.2022.38","article-title":"Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms","volume":"3","author":"Simonetta","year":"2023","journal-title":"Metab Target Organ Damage"},{"issue":"10","key":"10.1016\/j.aohep.2025.102139_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13101047","article-title":"Biomarker discovery for hepatocellular carcinoma in patients with liver cirrhosis using untargeted metabolomics and lipidomics studies","volume":"13","author":"Rashid","year":"2023","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.aohep.2025.102139_bib0051","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2025.102139_bib0052","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"72","author":"Clements","year":"2020","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.aohep.2025.102139_bib0053","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/17474124.2025.2545812","article-title":"Food insecurity is an emerging risk factor for liver disease: a scoping review","volume":"19","author":"Lonardo","year":"2025","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2025.102139_bib0054","doi-asserted-by":"crossref","first-page":"355","DOI":"10.20517\/jtgg.2024.70","article-title":"PNPLA3 as a driver of steatotic liver disease: navigating from pathobiology to the clinics via epidemiology","volume":"8","author":"Ralf","year":"2024","journal-title":"J Transl Genet Genom"},{"issue":"4","key":"10.1016\/j.aohep.2025.102139_bib0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.20517\/mtod.2022.20","article-title":"Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk","volume":"2","author":"Amedeo","year":"2022","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.aohep.2025.102139_bib0056","article-title":"Liver function indicators and risk of hepatocellular carcinoma: a bidirectional mendelian randomization study","volume":"14","author":"Qin","year":"2023","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.aohep.2025.102139_bib0057","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1053\/j.gastro.2020.01.028","article-title":"High serum levels of cholesterol increase antitumor functions of nature killer cells and reduce growth of liver tumors in mice","volume":"158","author":"Qin","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.aohep.2025.102139_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr Physiol"},{"issue":"5","key":"10.1016\/j.aohep.2025.102139_bib0059","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.12.023","article-title":"Exome-wide association study on alanine aminotransferase identifies sequence variants in the GPAM and APOE associated with fatty liver disease","volume":"160","author":"Jamialahmadi","year":"2021","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.aohep.2025.102139_bib0060","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","article-title":"Association of apolipoprotein E genotypes with lipid levels and coronary risk","volume":"298","author":"Bennet","year":"2007","journal-title":"Jama"},{"key":"10.1016\/j.aohep.2025.102139_bib0061","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/bs.apha.2015.04.003","article-title":"Bile acid metabolism and signaling in cholestasis, inflammation, and cancer","volume":"74","author":"Li","year":"2015","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.aohep.2025.102139_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2024.03.030","article-title":"Developing and validating clinical prediction models in hepatology - an overview for clinicians","author":"Strandberg","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102139_bib0063","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatol (Baltim Md)"},{"issue":"1","key":"10.1016\/j.aohep.2025.102139_bib0064","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2105\/AJPH.88.1.15","article-title":"Use and misuse of population attributable fractions","volume":"88","author":"Rockhill","year":"1998","journal-title":"Am J Public Health"},{"issue":"Suppl 1","key":"10.1016\/j.aohep.2025.102139_bib0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:57:44Z","timestamp":1784231864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125003643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1665268125003643"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102139","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparisons of global incidence and risk factor profiles of hepatocellular carcinoma and intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102139"}}